Name | 3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-amine |
Synonyms | ibrutinib N-1 Ibrutinib intermeidate N-1 Btk inhibitor 1 (R enantioMer) 3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyrimidin-4-amine 3-(4-phenoxyphenyl)-1-(3-piperidyl)pyrazolo[3,4-d]pyriMidin-4-aMine 3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylamine 3-(4-Phenoxy-phenyl)-1-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine (R)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyriMidin-4-aMine 3-(4-Phenoxy-phenyl)-1-(R)-piperidin-3-yl-1H-pyrazolo[3,4-d]pyriMidin-4-ylaMine |
CAS | 1022150-12-4 |
EINECS | 200-001-8 |
InChI | InChI=1S/C22H22N6O/c23-21-19-20(15-8-10-18(11-9-15)29-17-6-2-1-3-7-17)27-28(22(19)26-14-25-21)16-5-4-12-24-13-16/h1-3,6-11,14,16,24H,4-5,12-13H2,(H2,23,25,26) |
Molecular Formula | C22H22N6O |
Molar Mass | 386.45 |
Density | 1.39±0.1 g/cm3(Predicted) |
Melting Point | 133-136oC |
Boling Point | 626.3±55.0 °C(Predicted) |
Solubility | 10 mM in DMSO |
Appearance | Solid |
Color | White to Pale Yellow |
pKa | 9.00±0.10(Predicted) |
Storage Condition | under inert gas (nitrogen or Argon) at 2–8 °C |
Use | Intermediate |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.588 ml | 12.938 ml | 25.877 ml |
5 mM | 0.518 ml | 2.588 ml | 5.175 ml |
10 mM | 0.259 ml | 1.294 ml | 2.588 ml |
5 mM | 0.052 ml | 0.259 ml | 0.518 ml |
use | ibrutinib intermediate is an impurity reference substance, and is also used for drug declaration and testing. |